Publications & Works

Publication Network
Articles 9
All (9)
SCI-E, SSCI, AHCI (8)
SCI-E, SSCI, AHCI, ESCI (9)
Scopus (9)

1. Urinary Biomarker Profiles Define Divergent Pathways in Albuminuric and Non-Albuminuric Diabetic Kidney Disease

KAYGUSUZ Y., Özbek D. A., ERDUT A., Abanoz R., Korkut M. G., ÖZDEDE M., et al.
Kidney Diseases , pp.330-345, 2026 (SCI-Expanded, Scopus)

2. Interplay of gut microbiome and metabolome in various blood pressure phenotypes based on ambulatory BP monitoring reveal new insights in nondipper patients

Ozbek D. A., Koc N. S., Inal N., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.
JOURNAL OF HYPERTENSION , vol.43, no.9, pp.1539-1553, 2025 (SCI-Expanded, Scopus)

3. The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors

ŞAHİN T. K., GÜVEN D. C., Durukan M., KAVGACI G., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.25, no.4, pp.129-137, 2025 (SCI-Expanded, Scopus)

4. The association between HALP score and survival in patients treated with immune checkpoint inhibitors

ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY , vol.25, no.1, pp.81-89, 2025 (SCI-Expanded, Scopus)

5. The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study

ŞAHİN T. K., KAYGUSUZ Y., Icli M. C., AKSOY S., GÜVEN D. C.
CURRENT MEDICAL RESEARCH AND OPINION , vol.41, no.1, pp.83-91, 2025 (SCI-Expanded, Scopus)

6. Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors

KAVGACI G., GÜVEN D. C., KAYGUSUZ Y., KARACA E., DİZDAR Ö., Kilickap S., et al.
SUPPORTIVE CARE IN CANCER , vol.32, no.7, 2024 (SCI-Expanded, Scopus) Sustainable Development

7. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data

Guven D. C., ERUL E., KAYGUSUZ Y., Akagunduz B., Kilickap S., De Luca R., et al.
Supportive Care in Cancer , vol.31, no.12, 2023 (SCI-Expanded, Scopus)

8. Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab

YILDIRIM H. Ç., KUŞ F., GÜVEN D. C., Karaca E., KAYGUSUZ Y., DİZDAR Ö., et al.
Journal of Immunotherapy and Precision Oncology , vol.6, no.4, pp.170-176, 2023 (Scopus) Creative Commons License

9. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma

GÜVEN D. C., ERUL E., YILMAZ F., YAŞAR S., YILDIRIM H. Ç., ERCAN F., et al.
European Archives of Oto-Rhino-Laryngology , vol.280, no.5, pp.2471-2478, 2023 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences 1

1. Exploring the interplay between gut microbiome, fecal metabolomics and ambulatory blood pressure in white-coat hypertensive patients

ÖZBEK D. A., KOÇ N. S., nal N. e., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.
61st Congress of European-Renal-Association (ERA), Stockholm, Sweden, 23 - 26 May 2024, (Summary Text)
Metrics

Publication

10

Publication (WoS)

10

Publication (Scopus)

9

Citation (WoS)

24

H-Index (WoS)

1

Citation (Scopus)

35

H-Index (Scopus)

2

Project

1

Open Access

1
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING